無標題文件


	三軍總醫院新陳代謝科活動記事
	本網頁重整最新日期 -
	本院糖尿病衛教中心九月份衛教活動公佈於三軍總醫院門診表，包含代謝疾病與高血壓等議題，歡迎民眾踴躍參加聆聽。
	三軍總醫院，新陳代謝科謝昌勳醫師發表連續血糖監測系統(CGMS) 及守護者即時顯示血糖監測系統 (Guardian RT)新聞稿詳情請..
	本科謝昌勳醫師建立血糖監測系統有效控制糖尿病提昇衛教工作訓練，於中華日報刊載相關訊息。

	其他相關新聞與新知
	聯合國世界糖尿病日 (United Nations (UN) World Diabetes Day) 確定的糖尿病日益流行的趨勢全球糖尿病專家呼籲增加行動和分擔責任，抑制全球糖尿病的流行趨勢與影響


	三軍總醫院			洪乙仁 /Hung YJ, Chen YC, Pei D, Kuo SW, Hsieh CH, Wu LY, He CT, Lee CH, Fan SC, Sheu WH. Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes. Diabet Med. 2005 Aug;22(8):1024-30.
	三軍總醫院內科部
	網路掛號
	國防醫學院			洪乙仁 / Hung YJ, Hsieh CH, Pei D, Kuo SW, Lee JT, Wu LY, He CT, Lee CH, Fan SC, Sheu WH. Rosiglitazone improves insulin sensitivity and glucose tolerance in subjects with impaired glucose tolerance. Clin Endocrinol (Oxf). 2005 Jan;62(1):85-91.


				謝昌勳/Hsieh CH, Hung YJ, He CT, Lee CH, Hung SC, Wang YK, Kuo SW, Pei D. The capability of glucose toxicity on severe type 2 diabetes. Endocr Res. 2005;31(2):149-58.

				謝昌勳 /Hsieh CH, Kuo SW, Hung YJ, Shen DC, Ho CT, Lian WC, Lee CH, Fan SC, Pei D. Metabolic characteristics in individuals with impaired glucose homeostasis. Int J Clin Pract. 2005 Jun;59(6):639-44

				謝昌勳 /Hsieh CH, Kuo SW, Pei D, Hung YJ, Chyi-Fan S, Wu LI, He CT, Yang TC, Lian WC, Chien-Hsing L. Thyrotoxic periodic paralysis: an overview. Ann Saudi Med. 2004 Nov-Dec;24(6):418-22

				何志聰 / He CT, Hsieh AT, Pei D, Hung YJ, Wu LY, Yang TC, Lian WC, Huang WS, Kuo SW. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism. Clin Endocrinol (Oxf). 2004 Jun;60(6):676-81

				李建興 /Lee CH, Kuo SW, Hung YJ, Hsieh CH, He CT, Yang TC, Lian WC, Chyi-Fan S, Pei D. The effect of testosterone supplement on insulin sensitivity, glucose effectiveness, and acute insulin response after glucose load in male type 2 diabetics. Endocr Res. 2005;31(2):139-48.

洪乙仁 /Hung YJ, Chen YC, Pei D, Kuo SW, Hsieh CH, Wu LY, He CT, Lee CH, Fan SC, Sheu WH. Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes. Diabet Med. 2005 Aug;22(8):1024-30.